A phase II study of belumosudil for chronic graft-versus-host disease in patients who failed at least one line of systemic therapy in China. - Wang, Ying; Wu, Depei; Zhang, Xiang; Li, Yuhua; He, Yanjie; Liu, Qifa; Xuan, Li; Li, Zhenyu; Qi, Kunming; Sun, Yuqian; Wang, Shunqing; Mo, Wenjian; et al. (BMC Medicine, 2024)